Trials / Conditions / Myelodysplastic Disorders
Myelodysplastic Disorders
5 registered clinical trials studyying Myelodysplastic Disorders — 3 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Feasibility of a Multi-omics Platform for Hematological Malignancies NCT07445438 | Azienda Ospedaliero-Universitaria di Parma | N/A |
| Recruiting | INTEGRATIVE "MULTI-OMICS" AND FUNCTIONAL PLATFORM FOR THE COMPLETE DIAGNOSTIC CHARACTERIZATION OF TUMORS: THE NCT07403630 | Azienda Ospedaliero-Universitaria di Parma | N/A |
| Recruiting | Chemogenomic Profiling in Hematological Malignancies (HEM-Profiling 2021) NCT07445984 | Azienda Ospedaliero-Universitaria di Parma | N/A |
| Completed | Phase I-II Study of Idarubicin, Cytarabine, and Sorafenib (BAY43-9006) NCT00542971 | M.D. Anderson Cancer Center | Phase 1 / Phase 2 |
| Completed | Stem Cell Transplant for Patients With Blood Malignancy Using Donors and Less Toxic Chemotherapy With CAMPATH NCT00048412 | Baylor College of Medicine | Phase 1 / Phase 2 |